Carrageenan: Clinical Trials

6 trials of Carrageenan, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting, 1 unknown, 1 withdrawn. 3 Not applicable, 2 Phase 2, 1 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 2, Recruiting 1
Phase 22Completed 1, Withdrawn 1
Phase 11Completed 1
Phase 41Unknown 1

Follow Carrageenan: new trials by email Literature Review of Carrageenan trials Research Report on Carrageenan

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Investigating the Impact of the Seaweed Derived Food Additive, Carrageenan, on the Human Gut Microbiome
Carrageenan gummy sweet, Carrageenan and inulin gummy sweet, Placebo agar agar gummy - Gut Microbiome, Healthy Donors
Not applicableRecruitingUniversity of Reading992024-10-012024-12-17
Prophylaxis Covid-19 in Healthcare Agents by Intensive Treatment With Ivermectin and Iota-carrageenan
Ivermectin / Iota-Carrageenan - Covid19, SARS (Severe Acute Respiratory Syndrome)
Phase 1 / Phase 2CompletedMaria de los Angeles Peral de Bruno3002020-10-152021-02-23
Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Prophylaxis of COVID-19 Disease in Health Personnel Dedicated to Patients Care With COVID-19 Disease
Iota-Carrageenan - Covid19
Phase 4UnknownAriel Dogliotti4002020-07-242020-08-21
Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240)
Iota-Carrageenan, Carmellose - Adenoviral Conjunctivitis
Phase 2WithdrawnNicOx2017-01-012017-05-10
Study of Carrageenan's Effect on Insulin Resistance in Humans
Carrageenan, Placebo - Diabetes Mellitus, Type 2, Insulin Resistance
Not applicableCompletedUniversity Hospital Tuebingen202015-10-012018-10-18
Effects of Carrageenan-Elimination Diet on Ulcerative Colitis Disease Activity
carrageenan, dietary intervention with no-carrageenan diet - Ulcerative Colitis
Not applicableCompletedUniversity of Illinois at Chicago152010-01-012019-11-26

Conditions studied

COVID-19 (2)  ·  Colitis, Ulcerative (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Inflammation (1)  ·  Insulin Resistance (1)  ·  Recurrence (1)  ·  Severe Acute Respiratory Syndrome (1)

Sponsors

Ariel Dogliotti (1)  ·  Maria de los Angeles Peral de Bruno (1)  ·  NicOx (1)  ·  University Hospital Tuebingen (1)  ·  University of Illinois at Chicago (1)  ·  University of Reading (1)

Countries

Argentina (2)  ·  Germany (1)  ·  Spain (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Brigitte Duquesroix (1)  ·  Joanne Tobacman, M.D. (1)  ·  Juan Figueroa, MD (1)  ·  Robert Wagner, M.D (1)  ·  Rossana E Chahla, MD, Ph.D. (1)

Results publications

PMID 34629893, PMID 39593091